IBM gains $1.4B IT pact with AstraZeneca

IBM has inked a $1.4 billion, seven-year deal to manage AstraZeneca's IT infrastructure around the globe. The deal covers everything from PC management to servers and communications. "IBM will marshal its global resources to provide a flexible and agile infrastructure enabling AstraZeneca to continue implementing its plans to grow and lead in the pharmaceutical industry," said Doug Elix, Senior Vice President, IBM.

- check out the release on the IT deal

Related Articles:
AstraZeneca announces restructuring and buyout. Report
IBM to put worker genetic data off limits. Report
IBM hopes open source will open healthcare IT silos. Report
IBM introduces grid medical storage upgrade. Report

Suggested Articles

Bausch Health is paying $10 million upfront for the option to acquire Allegro Ophthalmics’ eye disease assets, with a promise of $40 million to come.

Anthony Coyle, Ph.D., has signed up to run Repertoire Immune Medicines’ R&D.

The IPO haul will set Kronos up to start a registrational phase 2/3 trial of a first-line AML drug licensed from Bischofberger's former employer.